212 related articles for article (PubMed ID: 34873727)
1. The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS).
Solan ME; Lavado R
J Appl Toxicol; 2022 Aug; 42(8):1298-1309. PubMed ID: 34873727
[TBL] [Abstract][Full Text] [Related]
2. Review of the zebrafish as a model to investigate per- and polyfluoroalkyl substance toxicity.
Rericha Y; Simonich MT; Truong L; Tanguay RL
Toxicol Sci; 2023 Jul; 194(2):138-152. PubMed ID: 37220906
[TBL] [Abstract][Full Text] [Related]
3. Comparative cytotoxicity of seven per- and polyfluoroalkyl substances (PFAS) in six human cell lines.
Solan ME; Senthilkumar S; Aquino GV; Bruce ED; Lavado R
Toxicology; 2022 Jul; 477():153281. PubMed ID: 35933025
[TBL] [Abstract][Full Text] [Related]
4. Patterns in Serum Toxicokinetics in Peromyscus Exposed to Per- and Polyfluoroalkyl Substances.
Narizzano AM; Bohannon ME; East AG; McDonough C; Choyke S; Higgins CP; Quinn MJ
Environ Toxicol Chem; 2021 Oct; 40(10):2886-2898. PubMed ID: 34236102
[TBL] [Abstract][Full Text] [Related]
5. Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.
Brase RA; Mullin EJ; Spink DC
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498193
[TBL] [Abstract][Full Text] [Related]
6. Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.
Pizzurro DM; Seeley M; Kerper LE; Beck BD
Regul Toxicol Pharmacol; 2019 Aug; 106():239-250. PubMed ID: 31078680
[TBL] [Abstract][Full Text] [Related]
7. Current Review of Increasing Animal Health Threat of Per- and Polyfluoroalkyl Substances (PFAS): Harms, Limitations, and Alternatives to Manage Their Toxicity.
Peritore AF; Gugliandolo E; Cuzzocrea S; Crupi R; Britti D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511474
[TBL] [Abstract][Full Text] [Related]
8. Per- and polyfluoroalkyl substances (PFAS) in livestock and game species: A review.
Death C; Bell C; Champness D; Milne C; Reichman S; Hagen T
Sci Total Environ; 2021 Jun; 774():144795. PubMed ID: 33609849
[TBL] [Abstract][Full Text] [Related]
9. Commentary: cumulative risk assessment of perfluoroalkyl carboxylic acids and perfluoralkyl sulfonic acids: what is the scientific support for deriving tolerable exposures by assembling 27 PFAS into 1 common assessment group?
Colnot T; Dekant W
Arch Toxicol; 2022 Nov; 96(11):3127-3139. PubMed ID: 35976416
[TBL] [Abstract][Full Text] [Related]
10. Concentration-dependent toxicokinetics of novel PFOS alternatives and their chronic combined toxicity in adult zebrafish.
Huang J; Liu Y; Wang Q; Yi J; Lai H; Sun L; Mennigen JA; Tu W
Sci Total Environ; 2022 Sep; 839():156388. PubMed ID: 35654180
[TBL] [Abstract][Full Text] [Related]
11. Assessing the human health risks of per- and polyfluoroalkyl substances: A need for greater focus on their interactions as mixtures.
Ojo AF; Peng C; Ng JC
J Hazard Mater; 2021 Apr; 407():124863. PubMed ID: 33373965
[TBL] [Abstract][Full Text] [Related]
12. A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics.
Niu S; Cao Y; Chen R; Bedi M; Sanders AP; Ducatman A; Ng C
Environ Health Perspect; 2023 Jul; 131(7):76002. PubMed ID: 37418334
[TBL] [Abstract][Full Text] [Related]
13. Per- and polyfluoroalkyl substances exposure and its influence on the intestinal barrier: An overview on the advances.
Li J; Wang L; Zhang X; Liu P; Deji Z; Xing Y; Zhou Y; Lin X; Huang Z
Sci Total Environ; 2022 Dec; 852():158362. PubMed ID: 36055502
[TBL] [Abstract][Full Text] [Related]
14. Association of emerging and legacy per- and polyfluoroalkyl substances with unexplained recurrent spontaneous abortion.
Nian M; Huo X; Zhang J; Mao Y; Jin F; Shi Y; Zhang J
Ecotoxicol Environ Saf; 2022 Jul; 239():113691. PubMed ID: 35643033
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
[TBL] [Abstract][Full Text] [Related]
16. Binding of Per- and Polyfluoroalkyl Substances (PFAS) to Serum Proteins: Implications for Toxicokinetics in Humans.
Fischer FC; Ludtke S; Thackray C; Pickard HM; Haque F; Dassuncao C; Endo S; Schaider L; Sunderland EM
Environ Sci Technol; 2024 Jan; 58(2):1055-1063. PubMed ID: 38166384
[TBL] [Abstract][Full Text] [Related]
17. Application of a Framework for Grouping and Mixtures Toxicity Assessment of PFAS: A Closer Examination of Dose-Additivity Approaches.
Goodrum PE; Anderson JK; Luz AL; Ansell GK
Toxicol Sci; 2021 Jan; 179(2):262-278. PubMed ID: 32735321
[TBL] [Abstract][Full Text] [Related]
18. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.
Fenton SE; Ducatman A; Boobis A; DeWitt JC; Lau C; Ng C; Smith JS; Roberts SM
Environ Toxicol Chem; 2021 Mar; 40(3):606-630. PubMed ID: 33017053
[TBL] [Abstract][Full Text] [Related]
19. Dietary exposure to per- and polyfluoroalkyl substances: Potential health impacts on human liver.
Zhang J; Hu L; Xu H
Sci Total Environ; 2024 Jan; 907():167945. PubMed ID: 37871818
[TBL] [Abstract][Full Text] [Related]
20. Baseline Toxicity Model to Identify the Specific and Nonspecific Effects of Per- and Polyfluoroalkyl Substances in Cell-Based Bioassays.
Qin W; Henneberger L; Glüge J; König M; Escher BI
Environ Sci Technol; 2024 Apr; 58(13):5727-5738. PubMed ID: 38394616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
